Molecular Templates (MTEM) Financials

$0.00

$0.00 (-96.15%)

As on 20-May-2025 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$25 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	25.47	57.31	19.75	38.70	18.85	19.50
Cost of Revenue	9.34	6.91	7.80	6.70	92.97	50.52
Gross Profit	16.14	50.40	11.95	38.70	18.85	-31.02
Operating Expenses	41.51	63.09	108.63	118.77	119.69	67.83
Operating Profit (EBIT)	-8.58	-10.47	-88.87	-80.07	-100.84	-70.45
Other Income	--	--	--	--	-3.39	0.00
Profit before Tax	-7.33	-8.14	-92.67	-83.01	104.91	-69.42
Provision for Tax	-0.41	-0.01	0.05	-3.70	0.01	0.12
Profit after Tax (Net Income)	-7.32	-8.12	-92.72	-79.31	104.92	-69.54
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-92.72	-83.01	-104.92	-69.42

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	7.11	4.21	-15.13	65.66	59.34	103.03
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	11.91	13.85	55.60	80.03	42.98	35.37
Current Liabilities	7.68	17.32	57.08	46.67	37.55	35.80
Total Liabilities	34.38	35.38	97.55	192.36	139.88	174.20

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	14.68	18.61	29.25	44.15	38.55	34.30
Current Assets	12.02	16.77	68.30	148.22	101.32	139.90
Total Assets	34.38	35.38	97.55	192.36	139.88	174.20
Total Debt*	11.03	12.23	50.58	45.06	27.14	17.48
Net Current Assets	4.34	-0.55	11.22	101.55	63.77	104.10

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-41.82	-89.02	-30.39	-83.80	-25.24
Cash Flow from Investing Activities	--	--	95.32	-62.44	-34.66	-39.72
Cash from Financing Activities	--	-9.12	-0.27	92.59	58.90	65.70
Net Cash Inflow / Outflow	--	--	--	-0.24	-59.57	0.73

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-1.07	-1.51	-24.68	-21.13	31.49	-25.72
Cash EPS ($)	--	-0.16	-22.71	-19.36	32.67	-25.28
Adjusted Book Value ($)	--	0.78	--	17.49	17.81	38.11
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-7.78	-23.70	-8.10	-25.15	-9.34
Free Cash Flow per Share ($)	--	-7.82	-24.55	-9.16	-27.37	-12.91

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-31.31	-126.87	-80.44	101.37	-60.46
ROE (%)	-129.29	148.79	-366.98	-126.90	129.23	-68.20
ROA (%)	-15.12	-12.22	-63.96	-47.75	66.81	-44.24
EBIT Margin (%)	-63.50	-9.56	-444.89	-206.93	565.81	-361.30
Net Margin (%)	-28.74	-14.18	-469.36	-204.96	678.94	-356.56
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-45.93	1.90	-0.49	1.05	-0.03	1.68
EBIT Growth (%)	63.51	93.76	-9.75	-175.10	251.35	-125.64
Net Profit Growth (%)	85.07	91.24	-16.90	-175.60	250.88	-129.59
EPS Growth (%)	84.53	0.94	-0.17	-1.67	2.22	-1.07
Book Value Growth (%)	146.95	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-2.47	-0.01	-0.19	0.30	-0.54
Price / Book Value	0.00	4.76	-0.08	0.22	0.53	0.37
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.15	14.51	0.12	1.13	-0.32	1.52
Close Price ($)	1.15	3.73	4.92	58.80	140.85	209.78
High Price ($)	9.45	9.56	63.60	227.85	286.84	217.79
Low Price ($)	1.01	3.26	4.65	49.50	112.65	57.23
Market Cap ($ Cr)	0.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	2.90	-3.34	0.69	0.46	0.17
Short term debt to equity ratio	0.37	0.59	-0.14	0.04	0.04	0.14
Current Ratio	1.56	0.97	1.20	3.18	2.70	3.91
Quick Ratio	1.56	--	--	--	2.54	3.72
Interest Coverage	-51.74	-2.07	-18.38	-23.77	62.54	-54.28

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	3.12	0.44	--	--	1.24	38.50
Asset Turnover	0.53	0.86	0.14	0.23	0.12	0.12
Receivable days	--	1.59	--	2.21	75.03	72.57
Inventory Days	--	--	--	331.45	25.34	32.76
Payable days	--	53.56	49.54	107.99	7.49	8.12
Cash Conversion Cycle	--	--	--	225.67	92.87	97.21

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.